EBR Systems, Inc. (ASX:EBR)

Market Cap	268.07M -48.3%
Revenue (ttm)	2.42M
Net Income	-73.10M
EPS	-0.18
Shares Out	450.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	458,354
Average Volume	646,963
Open	0.6300
Previous Close	0.6300
Day's Range	0.5900 - 0.6400
52-Week Range	0.5750 - 1.4750
Beta	0.59
RSI	40.32
Earnings Date	May 13, 2026

About EBR Systems

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 135
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EBR

Financial Performance

Financial numbers in USD